Antibodies to ILT3 abrogate myeloid immunosuppression and enable tumor killing
Philip E. Brandish, Anthony Palmieri, Gulesi Ayanoglu, Jeanne Baker, Raphael Bueno, Alan Byford, Michael Caniga, Craig Chappell, Holly Cherwinski, Daniel J. Cua, Xiaoyan Du, Laurence Fayadat-Dilman, Brian E. Hall, Hassan Issafras, Barbara Joyce-Shaikh, Veronica Juan, Rachel D. Levy, Andrey Loboda, Jared Lunceford, Carl Mieczkowski, Michael Meehl, Yujie Qu, Michael Rosenzweig, Latika Singh, Peter Stivers, Peter J. Tramontozzi, Kimberly Vermilya, Karin Vroom, Douglas C. Wilson, Chungsheng Zhang, Jie Zhang-Hoover
bioRxiv 2021.12.18.472552; doi: https://doi.org/10.1101/2021.12.18.472552 New Results
